All posts by: Michael Zand

About Michael Zand

A vaccine for edible plants? A new plant protection method on the horizon – Science Daily

Continue reading

2018-04-05 NEWS

Science Daily

A vaccine for edible plants? A new plant protection method on the horizon
Science Daily
As part of the Academy of Finland’s Synthetic Biology Research Programme, Poranen’s group has developed a new production method for double-stranded RNA molecules. Together with researchers at the CNRS, the group has demonstrated the efficacy of RNA

and more »

Continue reading

2018-04-05 NEWS

The Pharmaceutical Journal

Immunotherapy for type 1 diabetes: what’s in the pipeline?
The Pharmaceutical Journal
Another major reason for the absence of licensed immunotherapies is that clinicians have not been keen to refer T1D patients on to trials of this class of drugs, says Dayan, who also heads the clinical engagement and training core of the T1D UK

Continue reading

2018-04-05 NEWS

Liver Renewed by Telomerase-Expressing Stem Cells
Genetic Engineering & Biotechnology News
The liver’s amazing ability to repair itself is the stuff of legend and, increasingly, scientific understanding. A new study, for example, has found that liver repair is aided by a diffuse population of rare stem cells. These stem cells produce

and more »

Continue reading

2018-04-05 NEWS

Medical Xpress

Immunotherapy—cancer’s new frontier
Medical Xpress
Many cancer researchers are optimistic about immunotherapy, a treatment that harnesses the power of the immune system, teaching it to recognize—and destroy—cancer cells. “An educated immune cell, like a guided missile, can specifically recognize and
Kineta Immuno-oncology Unveils New Data Demonstrating Tumor Immunity in Multiple Tumor ModelsPR Newswire (press release)

all 3 news articles »

Continue reading

2018-04-05 NEWS

Cosmos

The vision thing: stem cell procedures produce stunning macular degeneration results
Cosmos
For 20 years, we’ve been waiting for human embryonic stem cells to deliver on their promise to provide new body parts, and deliver new treatments for diabetes, spinal cord injury, Parkinson’s or heart disease. But when it comes to this tortoise race to
Human Embryonic Stem Cell Implants Show Promise in Macular DegenerationR & D Magazine

all 10 news articles »